1-3 of 3
Ilhan Tezcan
Close
Sort by
Journal Articles

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency

Maria Pia Cicalese, Francesca Ferrua, Laura Castagnaro, Roberta Pajno, Federica Barzaghi, Stefania Giannelli, Francesca Dionisio, Immacolata Brigida, Marco Bonopane, Miriam Casiraghi, Antonella Tabucchi, Filippo Carlucci, Eyal Grunebaum, Mehdi Adeli, Robbert G. Bredius, Jennifer M. Puck, Polina Stepensky, Ilhan Tezcan, Katie Rolfe, Erika De Boever, Rickey R. Reinhardt, Jonathan Appleby, Fabio Ciceri, Maria Grazia Roncarolo, Alessandro Aiuti
Journal: Blood
Blood (2016) 128 (1): 45–54.
https://doi.org/10.1182/blood-2016-01-688226
Published: 2016
Includes: Supplemental data
Journal Articles

Identification of ITK deficiency as a novel genetic cause of idiopathic CD4 + T-cell lymphopenia

Nina Kathrin Serwas, Deniz Cagdas, Sol A. Ban, Kirsten Bienemann, Elisabeth Salzer, İlhan Tezcan, Arndt Borkhardt, Ozden Sanal, Kaan Boztug
Journal: Blood
Blood (2014) 124 (4): 655–657.
https://doi.org/10.1182/blood-2014-03-564930
Published: 2014
Journal Articles

Incomplete T-Cell Immune Reconstitution in Two Major Histocompatibility Complex Class II–Deficiency/Bare Lymphocyte Syndrome Patients After HLA-Identical Sibling Bone Marrow Transplantation

Barbara C. Godthelp, Marja C.J.A. van Eggermond, Ad Peijnenburg, Ilhan Tezcan, Stefaan van Lierde, Maarten J.D. van Tol, Jaak M. Vossen, Peter J. van den Elsen
Journal: Blood
Blood (1999) 94 (1): 348–358.
https://doi.org/10.1182/blood.V94.1.348.413k05_348_358
Published: 1999